Novozymes B A/S
Novozymes B A/S
-0,36 %
304,60 DKK
-1,10
Kurs
304,60
Hög
308,00
Förändring
-0,36 %
Låg
303,90
Uppdaterad
16:13:01
Öppen
305,00
Factsheet for Novozymes B A/S
Company Profile
Description
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.
Key Stats
Website: http://www.novozymes.com
Headquarter country: Denmark
Employees: 6 149
Market Cap (at close 25-06-2019): DKK 87B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 26,90 33,80 25,30 37,50 33,10
Forward Price/Earnings 24,00 30,70 22,40 30,90 33,20
Price/Free Cash Flow 37,80 42,10 29,70 53,50 18,40
Return on Assets 16,90 16,80 16,70 15,60 14,50
Return on Equity 28,40 27,10 26,20 24,70 22,60
Return on Invested Capital 22,90 23,20 23,30 21,90 19,80
Dividend


Dividend/Share:4,50
Ex. Dividend Date:2018-12-31
Trailing Dividend Yield:1,65
Payout Ratio:46,69
Date Currency Amount
2019-03-31 DKK 5,00
2018-03-31 DKK 4,50
2017-03-31 DKK 4,00
2016-03-31 DKK 3,50
2015-03-31 DKK 3,00
2014-03-31 DKK 2,50
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 14 390,00 14 531,00 14 142,00 14 002,00 12 459,00
Gross Profit 8,26 8,41 8,13 8,13 7,15
Gross Margin % 57,37% 57,90% 57,46% 58,06% 57,38%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 4 960,00 4 943,00 4 886,00 4 605,00 4 203,00
Net income 3 226,00 3 119,00 3 050,00 2 823,00 2 526,00
Basic Earnings Per Share 11,11 10,56 10,15 9,23 8,10
Operating Income 4,07 4,11 3,95 3,88 3,15
Operating Margin % 28,28% 28,31% 27,90% 27,74% 25,26%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 3 679,00 4 063,00 3 840,00 3 339,00 4 525,00
Capital Expenditures -1 392,00 -1 692,00 -1 216,00 -1 031,00 -723,00
Free Cash Flow 2 287,00 2 371,00 2 624,00 2 308,00 3 802,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 6 835,00 6 137,00 6 393,00 6 148,00 7 311,00 5 830,00
Long Term Assets 12 862,00 12 236,00 12 266,00 11 643,00 11 115,00 10 676,00
Total Assets 19 697,00 18 373,00 18 659,00 17 791,00 18 426,00 16 506,00
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 5 525,00 4 577,00 3 562,00 3 300,00 3 941,00 2 599,00
Long Term Liabilities 2 542,00 3 365,00 2 911,00
Total Liabilities 7 119,00 6 927,00 6 211,00
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 10 943,00 10 861,00 10 483,00 10 396,00 10 209,00 10 246,00
Treasury Stock
Total Stockholder Equity 11 425,00 11 254,00 11 732,00 11 580,00 11 269,00 11 054,00
Net Tangible Assets 9 295,00 8 822,00 8 995,00 8 904,00 8 315,00 8 190,00